ACOD1 and central nervous system cancer: Also, Acod1 expression increased CD14+ cells in ovarian carcinoma patients and correlated with glioma progression [81], two observations suggesting that the Acod1/itaconate metabolic pathway plays a pivotal role in certain types of cancers.